RBC Capital Maintains Outperform on Encompass Health, Raises Price Target to $105
Portfolio Pulse from Benzinga Newsdesk
RBC Capital analyst Ben Hendrix has maintained an 'Outperform' rating on Encompass Health (NYSE:EHC) and raised the price target from $95 to $105.
September 26, 2024 | 2:50 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
RBC Capital has reaffirmed its 'Outperform' rating for Encompass Health and increased the price target from $95 to $105, indicating positive expectations for the stock.
The increase in price target from $95 to $105 by RBC Capital suggests a positive outlook for Encompass Health, likely leading to a short-term increase in stock price. The 'Outperform' rating indicates confidence in the company's performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100